3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Motor Activity
4
Neoplasms
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Obesity
2
Colorectal Neoplasms
2
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Skin Neoplasms
1
Sarcopenia
1
Renal Insufficiency, Chronic
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Overweight
1
Neoplasms, Plasma Cell
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Lung Neoplasms
1
Locally Advanced Head and Neck Squamous Cell Carcinoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Inflammation
1
Hematopoietic and Lymphatic System Neoplasm
1
Endometrial Neoplasms
1
Endometrial Hyperplasia
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
daratumumab
4
Lenalidomide
3
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Dexamethasone
2
Curcumin
2
Calcium Dobesilate
2
piperine
1
isatuximab
1
iberdomide
1
Watchful Waiting
1
Stem Cell Transplantation
1
Peripheral Blood Stem Cell Transplantation
1
Observation
1
Melphalan
1
Leflunomide
1
IPH-2101
1
Dietary Fiber
1
Diet, Mediterranean
1
Cholestyramine Resin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Smoldering Multiple Myeloma
×
Resistance Training
×
90 days
×
Clear all
No trials found.